Cargando…

Glycyrrhetinic acid regulates impaired macrophage autophagic flux in the treatment of non-alcoholic fatty liver disease

Macrophages are involved in hepatocyte steatosis and necroinflammation and play an important role in the pathogenesis of non-alcoholic fatty liver disease (NAFLD). Impaired autophagy function (decreased autophagy or blocked autophagic flow) leads to cell damage and death and promotes NAFLD progressi...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Yadong, Dong, Wenjin, Wang, Ying, Zhu, Shan, Chai, Rundong, Xu, Zhe, Zhang, Xiaoyu, Yan, Yiqi, Yang, Long, Bian, Yuhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365971/
https://www.ncbi.nlm.nih.gov/pubmed/35967372
http://dx.doi.org/10.3389/fimmu.2022.959495
_version_ 1784765452443975680
author Fan, Yadong
Dong, Wenjin
Wang, Ying
Zhu, Shan
Chai, Rundong
Xu, Zhe
Zhang, Xiaoyu
Yan, Yiqi
Yang, Long
Bian, Yuhong
author_facet Fan, Yadong
Dong, Wenjin
Wang, Ying
Zhu, Shan
Chai, Rundong
Xu, Zhe
Zhang, Xiaoyu
Yan, Yiqi
Yang, Long
Bian, Yuhong
author_sort Fan, Yadong
collection PubMed
description Macrophages are involved in hepatocyte steatosis and necroinflammation and play an important role in the pathogenesis of non-alcoholic fatty liver disease (NAFLD). Impaired autophagy function (decreased autophagy or blocked autophagic flow) leads to cell damage and death and promotes NAFLD progression. The experimental and clinical research of glycyrrhetinic acid (GA) in the treatment of NAFLD has gradually attracted attention with clear pharmacological activities such as immune regulation, antiviral, antitumor, antioxidant, liver protection, and anti-inflammatory. However, the effects of GA on the STAT3-HIF-1α pathway and autophagy in macrophages are still unclear, and its mechanism of action in the treatment of NAFLD remains to be further elucidated. We constructed a NAFLD mouse model through a high-fat and high-sugar diet to investigate the therapeutic effects of GA. The results showed that GA reduced weight, improved the pathological changes and hepatic lipid deposition of liver, and abnormally elevated the levels of serum biochemical (AST, ALT, TG, T-CHO, LDL-C, and HDL-C) and inflammatory indexes (IL-1β, IL-4, IL-6, MCP-1, and TNF-α) in NAFLD mice. Further examination revealed that GA ameliorates excessive hepatic macrophage infiltration and hepatocyte apoptosis. The results of the cell experiments further elaborated that GA modulated the PA-induced macrophage STAT3-HIF-1α pathway and ameliorated impaired autophagic flux (blockade of autophagosome–lysosome fusion) and overactivation of inflammation. Excessive hepatocyte apoptosis caused by the uncontrolled release of inflammatory cytokines was also suppressed by GA. CONCLUSION: This study demonstrated that GA could regulate the STAT3-HIF-1α pathway of macrophages, ameliorate the impaired autophagy flux, and reduce the excessive production of inflammatory cytokines to improve the excessive apoptosis of liver cells, thus playing a therapeutic role on NAFLD.
format Online
Article
Text
id pubmed-9365971
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93659712022-08-12 Glycyrrhetinic acid regulates impaired macrophage autophagic flux in the treatment of non-alcoholic fatty liver disease Fan, Yadong Dong, Wenjin Wang, Ying Zhu, Shan Chai, Rundong Xu, Zhe Zhang, Xiaoyu Yan, Yiqi Yang, Long Bian, Yuhong Front Immunol Immunology Macrophages are involved in hepatocyte steatosis and necroinflammation and play an important role in the pathogenesis of non-alcoholic fatty liver disease (NAFLD). Impaired autophagy function (decreased autophagy or blocked autophagic flow) leads to cell damage and death and promotes NAFLD progression. The experimental and clinical research of glycyrrhetinic acid (GA) in the treatment of NAFLD has gradually attracted attention with clear pharmacological activities such as immune regulation, antiviral, antitumor, antioxidant, liver protection, and anti-inflammatory. However, the effects of GA on the STAT3-HIF-1α pathway and autophagy in macrophages are still unclear, and its mechanism of action in the treatment of NAFLD remains to be further elucidated. We constructed a NAFLD mouse model through a high-fat and high-sugar diet to investigate the therapeutic effects of GA. The results showed that GA reduced weight, improved the pathological changes and hepatic lipid deposition of liver, and abnormally elevated the levels of serum biochemical (AST, ALT, TG, T-CHO, LDL-C, and HDL-C) and inflammatory indexes (IL-1β, IL-4, IL-6, MCP-1, and TNF-α) in NAFLD mice. Further examination revealed that GA ameliorates excessive hepatic macrophage infiltration and hepatocyte apoptosis. The results of the cell experiments further elaborated that GA modulated the PA-induced macrophage STAT3-HIF-1α pathway and ameliorated impaired autophagic flux (blockade of autophagosome–lysosome fusion) and overactivation of inflammation. Excessive hepatocyte apoptosis caused by the uncontrolled release of inflammatory cytokines was also suppressed by GA. CONCLUSION: This study demonstrated that GA could regulate the STAT3-HIF-1α pathway of macrophages, ameliorate the impaired autophagy flux, and reduce the excessive production of inflammatory cytokines to improve the excessive apoptosis of liver cells, thus playing a therapeutic role on NAFLD. Frontiers Media S.A. 2022-07-28 /pmc/articles/PMC9365971/ /pubmed/35967372 http://dx.doi.org/10.3389/fimmu.2022.959495 Text en Copyright © 2022 Fan, Dong, Wang, Zhu, Chai, Xu, Zhang, Yan, Yang and Bian https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Fan, Yadong
Dong, Wenjin
Wang, Ying
Zhu, Shan
Chai, Rundong
Xu, Zhe
Zhang, Xiaoyu
Yan, Yiqi
Yang, Long
Bian, Yuhong
Glycyrrhetinic acid regulates impaired macrophage autophagic flux in the treatment of non-alcoholic fatty liver disease
title Glycyrrhetinic acid regulates impaired macrophage autophagic flux in the treatment of non-alcoholic fatty liver disease
title_full Glycyrrhetinic acid regulates impaired macrophage autophagic flux in the treatment of non-alcoholic fatty liver disease
title_fullStr Glycyrrhetinic acid regulates impaired macrophage autophagic flux in the treatment of non-alcoholic fatty liver disease
title_full_unstemmed Glycyrrhetinic acid regulates impaired macrophage autophagic flux in the treatment of non-alcoholic fatty liver disease
title_short Glycyrrhetinic acid regulates impaired macrophage autophagic flux in the treatment of non-alcoholic fatty liver disease
title_sort glycyrrhetinic acid regulates impaired macrophage autophagic flux in the treatment of non-alcoholic fatty liver disease
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365971/
https://www.ncbi.nlm.nih.gov/pubmed/35967372
http://dx.doi.org/10.3389/fimmu.2022.959495
work_keys_str_mv AT fanyadong glycyrrhetinicacidregulatesimpairedmacrophageautophagicfluxinthetreatmentofnonalcoholicfattyliverdisease
AT dongwenjin glycyrrhetinicacidregulatesimpairedmacrophageautophagicfluxinthetreatmentofnonalcoholicfattyliverdisease
AT wangying glycyrrhetinicacidregulatesimpairedmacrophageautophagicfluxinthetreatmentofnonalcoholicfattyliverdisease
AT zhushan glycyrrhetinicacidregulatesimpairedmacrophageautophagicfluxinthetreatmentofnonalcoholicfattyliverdisease
AT chairundong glycyrrhetinicacidregulatesimpairedmacrophageautophagicfluxinthetreatmentofnonalcoholicfattyliverdisease
AT xuzhe glycyrrhetinicacidregulatesimpairedmacrophageautophagicfluxinthetreatmentofnonalcoholicfattyliverdisease
AT zhangxiaoyu glycyrrhetinicacidregulatesimpairedmacrophageautophagicfluxinthetreatmentofnonalcoholicfattyliverdisease
AT yanyiqi glycyrrhetinicacidregulatesimpairedmacrophageautophagicfluxinthetreatmentofnonalcoholicfattyliverdisease
AT yanglong glycyrrhetinicacidregulatesimpairedmacrophageautophagicfluxinthetreatmentofnonalcoholicfattyliverdisease
AT bianyuhong glycyrrhetinicacidregulatesimpairedmacrophageautophagicfluxinthetreatmentofnonalcoholicfattyliverdisease